☆ 4.8 Letter

Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis

CIRCULATION (2022)

Get Full Text
Add to Collection

Journal

CIRCULATION
Volume 145, Issue 25, Pages 1875-1877

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.122.059405

Keywords

aspirin; coronary artery disease; peripheral artery disease; rivaroxaban; venous thromboembolism

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Funding

  1. Bayer AG

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.